Abstracts

MURINE MODEL TO PREDICT VIRAL REBOUND IN HIV+ ALLOTRANSPLANTED SUBJECTS

Allogeneic stem cell transplantation (SCT) in HIV-infected subjects with hematological malignancies considerably reduces the viral reservoir. However, because antiretroviral treatment (cART) is maintained in these patients, it is difficult to infer the dynamics of viral rebound if cART is withdrawn. Herein, we explore the mice viral outgrowth approach (mVOA) as a potential tool to predict…

SMALL-MOLECULE INHIBITION OF INTRINSIC STRESS PATHWAYS REDUCES HIV TRANSCRIPTION

Combination antiretroviral therapy (cART) effectively reduces HIV replication to undetectable levels, but HIV persists as a stable reservoir within resting memory CD4+ T cells. Substantial effort has been applied to identifying small molecules that can perturb the stability of this reservoir. Studies in model systems have identified many latency reversing agents (LRAs), but few are…

NNRTIs DECREASE HIV-1 PRODUCTION FROM RCD4+ T CELLS FOLLOWING LATENCY REVERSAL

Background: Therapeutic strategies which target the latent HIV-1 reservoir in resting CD4+ T cells of infected-individuals are always administered in the presence of combination antiretroviral (ART) therapy. In this study, we evaluated whether the different therapeutic classes of ARV drugs impacted HIV-1 latency reversal. Methods: Latency reversal was evaluated in a primary cell model of…